circRNA basic information
circBase ID: hsa_circ_0070934
Name: hsa_circ_LARP1B
Synonym: circ-LARP1B / hsa_circRNA_103737
Host Gene: LARP1B
Genomic location(hg19): chr4:128995614-129012667:+
Genomic location(hg38): chr4:128074459-128091512:+
Subcellular localization: cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0007256
MONDO name: hepatocellular carcinoma
Disease details: hepatocellular carcinoma / HCC
Disease DO ID:
684, 686
Disease MeSH ID:
D006528
Disease NCIt ID:
C3099
Disease ICD11 ID:
1294035808
Disease OMIM ID:
114550
Species: Human
Species details: Homo sapiens
Tissue specimen:

HCC tissues; matched non-cancer tissues; normal liver tissues; xenograft tumors

Cell lines:

MHCC97; Hep3B; Huh-7; THLE-2; HUVECs

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: IGF1R, LARP1B, Bcl-2, MMP9
Associated microRNA: miR-578
Biological function: circ-LARP1B promotes HCC tumorigenesis, cell proliferation, invasion, angiogenesis and radioresistance, while inhibiting apoptosis and radiosensitivity; circ-LARP1B knockdown suppresses malignant behaviors and enhances radiosensitivity in vitro and in vivo.
Molecular mechanism: circ-LARP1B acts as a cytoplasmic miRNA sponge/ceRNA that binds miR-578 and relieves miR-578-mediated repression of IGF1R, thereby up-regulating IGF1R and regulating HCC tumorigenicity and radiosensitivity.
Biological pathway or process:

proliferation (promotes); apoptosis (inhibits); invasion (promotes); angiogenesis (promotes); radioresistance (promotes); ceRNA regulation (other)

Detected method:
Q
M
Validation methods:

Microarray; RT-qPCR; RNase R Treatment; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; Transfection; CCK8; Colony Formation Assay; EdU Staining; Annexin V/PI Flow Cytometry; Transwell Assay; Tube Formation Assay; Western Blot; Luciferase Reporter Assay; In Vivo Animal Model; IHC (Immunohistochemistry); Survival Analysis; Bioinformatics Analysis

Clinical significance:

High circ-LARP1B expression is associated with shorter overall survival and poor outcomes in HCC patients, suggesting prognostic value and a potential therapeutic target.

Description:

circ-LARP1B is up-regulated in HCC tissues and cells, and its high expression predicts poor overall survival. Functionally, circ-LARP1B promotes HCC tumorigenic phenotypes and radioresistance; knockdown suppresses proliferation, invasion, angiogenesis and tumor growth while enhancing radiosensitivity. Mechanistically, cytoplasmic circ-LARP1B sponges miR-578 to up-regulate IGF1R.

Confidence score:

0.8156

Other information
Title:

Circ-LARP1B knockdown restrains the tumorigenicity and enhances radiosensitivity by regulating miR-578/IGF1R axis in hepatocellular carcinoma.

Journal: Annals of hepatology
Published: 2022
PubMed ID: 35093599
Study type:

combined biological and clinical study

Data availability: GSE91332; Please contact the correspondence author for the data request.
Code availability: -